MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2019 International Congress

    Somatization disorder (SD) and Parkinson’s Disease (PD) in Mexican population

    M. Rodriguez-Violante, A. Cervantes-Arriaga, A. Polo-Morales, A. Alcocer-Salas (Ciudad de México, Mexico)

    Objective: Identify, in Mexican patients with PD, the prevalence of SD as well as its impact on cognitive and motor impairment. Background: SD refers to…
  • 2019 International Congress

    Discriminative power of different olfactory domains in Parkinson’s disease

    YW. Zhao, RC. He, JX. Yang, Y. Zhang, XT. Zhou, XX. Zhou, LX. Qin, Y. Tian, ZQ. Wang, QY. Sun, Q. Xu, JC. Li, JF. Guo, XX. Yan, BS. Tang (Changsha, China)

    Objective: The aim of this study was to evaluate which kind of olfactory domain was the best in discriminating PD patients from controls, and to…
  • 2019 International Congress

    Effect of Deep brain stimulation and Continuous infusion of levodopa-carbidopa intestinal therapy on non-motor symptoms in patients with advance Parkinson’s disease

    V. Vuletic (Rijeka, Croatia)

    Objective: Our aim was to see effects of deep brain stimulation (DBS) and continuous infusion of levodopa-carbidopa intestinal gel (LCIG) on nonmotor symptoms in advanced…
  • 2019 International Congress

    Construct validity of the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS)

    KR. Chaudhuri, A. Rizos, C. Rodriguez-Blazquez, D. Weintraub, A. Schrag, P. Martinez-Martin (London, United Kingdom)

    Objective: To analyze the construct validity of the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS). Background: The MDS-NMS is a new instrument that…
  • 2018 International Congress

    Trust the Patient not the Doctor: Health-related Quality of Life in Cervical Dystonia

    M. Al Hussona, J. Dover, I. Ndukwe, S. O'Riordan, R. Beck, R. Reilly, M. Hutchinson (Dublin, Ireland)

    Objective: Assess measures on health-related quality-of-life, and anxiety and depression in patients with cervical dystonia attending University Hospital specialist clinic. Background: Non-motor symptoms are a…
  • 2018 International Congress

    Characteristics in relation to demographic, disease related and clinical variables of a cohort of Parkinson’s disease patients from Northern Sri Lanka

    A. Keshavaraj, S. Kunathilagam (Jaffna, Sri Lanka)

    Objective: To evaluate motor and non-motor domains, as well as for demographic and disease related characteristics of patients with Parkinson’s disease and the relations with…
  • 2018 International Congress

    Non-motor outcomes of subthalamic DBS in PD depend on the location of volume of activated tissue

    JN. Petry-Schmelzer, H. Dafsari, M. Krause, T. Dembek, A. Keyoumars, A. Rizos, M. Silverdale, J. Evans, M. Barbe, G. Fink, P. Martinez-Martin, V. Visser-Vandewalle, A. Antonini, L. Timmermann, K. Ray-Chaudhuri (Cologne, Germany)

    Objective: To investigate the impact of stimulation location on non-motor symptoms (NMS) in PD patients with DBS in the subthalamic nucleus (STN) via an analysis…
  • 2018 International Congress

    Stigma and communication in people with Parkinson’s disease (PPD)

    M. Bacigalupe (La Plata, Argentina)

    Objective: To present results about stigma in PPD from a Parkinson’s Workshop. These are preliminary results in the path to address the main project question…
  • 2018 International Congress

    Prevalence and Correlates of Anxiety & Depression in Cervical Dystonia

    M. Al Hussona, I. Ndukwe, S. O'Riordan, R. Beck, R. Reilly, M. Hutchinson (Dublin, Ireland)

    Objective: Our aim was to assess the prevalence and severity of mood disorder in our Cervical Dystonia population attending the botulinum toxin clinic and to…
  • 2018 International Congress

    Higher Levels of Serum Uric Acid Associated with Motor & Non-Motor Symptoms in Early Parkinson’s Disease

    N. Chia, W.L. Au, Z. Lu, X. Huang, S. Ng, S. Acharyya, F. Setiawan, E. Ng, K.Y. Tay, E.K. Tan, L. Tan (Singapore, Singapore)

    Objective: Uric acid (UA) has been shown to be potentially neuroprotective in Parkinson's disease (PD), a progressive neurodegenerative disorder that is clinically characterised by motor…
  • « Previous Page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • …
  • 55
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley